Abstract 1017: The BRD-inhibitor OTX015 affects proliferation and gene expression of cells derived from mature lymphoid neoplasms.
Paola Bonetti(Center for Pediatric Endocrinology Zurich), Francesco Bertoni(Ente Ospedaliero Cantonale), Eugenia Riveiro, Andrea Rinaldi(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Anastasios Stathis(Princess Margaret Cancer Centre), Elena Bernasconi(Institute of Oncology Research), Michela Boi(Cornell University), Ivo Kwee(Dalle Molle Institute for Artificial Intelligence Research), Emanuele Zucca(Università della Svizzera italiana), Eugenio Gaudio(Institute of Oncology Research), Giorgio Inghirami(Cornell University), Maria Grazia Tibiletti(University of Insubria), Maurilio Ponzoni(San Raffaele University of Rome)
Cited by 0
Related Papers
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
|Proceedings of the National Academy of Sciences|2012|1.5k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
|Gastroenterology|1997|1.4k
Advanced pancreatic carcinoma: current treatment and future challenges
|Nature Reviews Clinical Oncology|2010|791